Matrix metalloproteinases (MMPs) are a family of 25 enzymes that proteolytically process extracellular matrix and inflammatory proteins, making them highly relevant in ischaemic remodelling after myocardial infarction. In this Review, Lindsey focuses on systems biology approaches to integrate the roles of MMPs in left ventricular remodelling, using MMP9 as an example.